What is she best known for?
The fields of study she is best known for:
- Gene
- Cancer
- Internal medicine
Her primary areas of study are Cancer research, Chronic lymphocytic leukemia, Immunology, Leukemia and Internal medicine.
Her Cancer research research is multidisciplinary, incorporating elements of Cancer, Gene rearrangement, Apoptosis, Mantle cell lymphoma and Kinase.
Her studies in Chronic lymphocytic leukemia integrate themes in fields like Fludarabine and Transplantation.
In her study, Computational biology and K562 cells is inextricably linked to Bioinformatics, which falls within the broad field of Leukemia.
The Internal medicine study combines topics in areas such as Gastroenterology, Surgery and Oncology.
Her research investigates the connection between [email protected] and topics such as Mutation that intersect with problems in Germline.
Her most cited work include:
- Loss of acetylation at Lys16 and trimethylation at Lys20 of histone H4 is a common hallmark of human cancer (1438 citations)
- ZAP-70 Expression as a Surrogate for Immunoglobulin-Variable-Region Mutations in Chronic Lymphocytic Leukemia (1218 citations)
- Whole-genome sequencing identifies recurrent mutations in chronic lymphocytic leukaemia (1195 citations)
What are the main themes of her work throughout her whole career to date?
The scientist’s investigation covers issues in Cancer research, Chronic lymphocytic leukemia, Immunology, Internal medicine and Leukemia.
Her Cancer research research incorporates elements of Apoptosis, Mantle cell lymphoma, Bortezomib, Cytotoxic T cell and Cyclin D1.
The study incorporates disciplines such as Mutation, CD5 and Fludarabine in addition to Chronic lymphocytic leukemia.
She studies B cell, a branch of Immunology.
Her Internal medicine research includes themes of Gastroenterology, Surgery and Oncology.
Her Leukemia research focuses on Myeloid leukemia and how it relates to Molecular biology.
She most often published in these fields:
- Cancer research (36.02%)
- Chronic lymphocytic leukemia (29.30%)
- Immunology (27.15%)
What were the highlights of her more recent work (between 2015-2021)?
- Cancer research (36.02%)
- Chronic lymphocytic leukemia (29.30%)
- Internal medicine (26.61%)
In recent papers she was focusing on the following fields of study:
Dolors Colomer mainly investigates Cancer research, Chronic lymphocytic leukemia, Internal medicine, Oncology and Leukemia.
She interconnects Cytotoxic T cell, Adoptive cell transfer, Mantle cell lymphoma and Ibrutinib in the investigation of issues within Cancer research.
Her Chronic lymphocytic leukemia study is concerned with Immunology in general.
Her Internal medicine research incorporates themes from Gastroenterology, DNA sequencing and Cardiology.
The concepts of her Oncology study are interwoven with issues in Clinical trial, Cytarabine, Myelodysplastic syndromes, Myelofibrosis and Acute leukemia.
The various areas that Dolors Colomer examines in her Leukemia study include MAPK/ERK pathway and Companion diagnostic.
Between 2015 and 2021, her most popular works were:
- The Bruton Tyrosine Kinase (BTK) Inhibitor Acalabrutinib Demonstrates Potent On-Target Effects and Efficacy in Two Mouse Models of Chronic Lymphocytic Leukemia. (57 citations)
- Clinical impact of the subclonal architecture and mutational complexity in chronic lymphocytic leukemia. (46 citations)
- Control of chronic lymphocytic leukemia development by clonally-expanded CD8(+) T-cells that undergo functional exhaustion in secondary lymphoid tissues (31 citations)
In her most recent research, the most cited papers focused on:
- Gene
- Cancer
- Internal medicine
Her primary areas of investigation include Cancer research, Chronic lymphocytic leukemia, Immunology, Leukemia and Lymphoma.
Her Cancer research study combines topics from a wide range of disciplines, such as Mantle cell lymphoma, Transcriptional regulation, Tumor progression, Cyclin D1 and Cyclin.
Her Chronic lymphocytic leukemia research focuses on Mutation and how it connects with MAPK/ERK pathway and Genome.
Her study in Immunology is interdisciplinary in nature, drawing from both Bruton's tyrosine kinase and In vivo.
Her study explores the link between Leukemia and topics such as Adoptive cell transfer that cross with problems in Signal transduction, Cytokine secretion and Myeloid.
Dolors Colomer focuses mostly in the field of Lymphoma, narrowing it down to matters related to Oncology and, in some cases, Internal medicine, Young adult, Incidence, Cancer and International Prognostic Index.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
